Paul J. Clancy

2016

In 2016, Paul J. Clancy earned a total compensation of $5.4M as Former Executive Vice President, Finance and Chief Financial Officer at Biogen, a 36% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$55,376
Non-Equity Incentive Plan$728,818
Salary$844,600
Stock Awards$3,556,773
Other$199,635
Total$5,385,202

Clancy received $3.6M in stock awards, accounting for 66% of the total pay in 2016.

Clancy also received $55.4K of change in pension value and nonqualified deferred compensation earnings, $728.8K in non-equity incentive plan, $844.6K in salary and $199.6K in other compensation.

Rankings

In 2016, Paul J. Clancy's compensation ranked 1,433rd out of 14,075 executives tracked by ExecPay. In other words, Clancy earned more than 89.8% of executives.

ClassificationRankingPercentile
All
1,433
out of 14,075
90th
Division
Manufacturing
486
out of 5,489
91st
Major group
Chemicals And Allied Products
135
out of 1,895
93rd
Industry group
Drugs
91
out of 1,538
94th
Industry
Biological Products, Except Diagnostic Substances
18
out of 279
94th
Source: SEC filing on April 27, 2018.

Clancy's colleagues

We found five more compensation records of executives who worked with Paul J. Clancy at Biogen in 2016.

2016

George Scangos

Biogen

Chief Executive Officer

2016

Michel Vounatsos

Biogen

Chief Executive Officer

2016

Michael Ehlers

Biogen

Executive Vice President, Research & Development

2016

Kenneth DiPietro

Biogen

Former Executive Vice President, Human Resources

2016

Susan Alexander

Biogen

Chief Legal Officer

You may also like